Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years The Cardiovascular Health Study by Drazner, Mark H et al.
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OBJECTIVES Our aim in this study was to determine whether increased left ventricular mass (LVM) is a
risk factor for the development of a reduced left ventricular ejection fraction (LVEF).
BACKGROUND Prior studies have shown that increased LVM is a risk factor for heart failure but not whether
it is a risk factor for a low LVEF.
METHODS As part of the Cardiovascular Health Study, a prospective population-based longitudinal
study, we performed echocardiograms upon participant enrollment and again at follow-up of
4.9  0.14 years. In the present analysis, we identified 3,042 participants who had at baseline
a normal LVEF and an assessment of LVM (either by electrocardiogram or echocardiogram),
and at follow-up a measurable LVEF. The frequency of the development of a qualitatively
depressed LVEF on two-dimensional echocardiography, corresponding approximately to an
LVEF 55%, was analyzed by quartiles of baseline LVM. Multivariable regression
determined whether LVM was independently associated with the development of depressed
LVEF.
RESULTS Baseline quartile of echocardiographic LVM indexed to body surface area was associated with
development of a depressed LVEF (4.8% in quartile 1, 4.4% in quartile 2, 7.5% in quartile 3,
and 14.1% in quartile 4 [p  0.001]). A similar relationship was seen in the subgroup of
participants without myocardial infarction (p  0.001). In multivariable regression that
adjusted for confounders, both baseline echocardiographic (p  0.001) and electrocardio-
graphic (p  0.001) LVM remained associated with development of depressed LVEF.
CONCLUSIONS Increased LVM as assessed by electrocardiography or echocardiography is an independent
risk factor for the development of depressed LVEF. (J Am Coll Cardiol 2004;43:2207–15)
© 2004 by the American College of Cardiology Foundationv
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Increased left ventricular mass (LVM) and left ventricular
LV) hypertrophy are important independent predictors of
ardiovascular morbidity including heart failure in popula-
ion studies (1–7). However, prior studies have not reported
ow often the heart failure attributed to LV hypertrophy
ccurred in the setting of a depressed or preserved left
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resent in a significant number of patients with heart failure
n epidemiologic studies (8–10). Additionally, heart failure
n the presence of LV hypertrophy and a preserved LVEF
See page 2216
ay be due to related diastolic dysfunction (11,12). To our
nowledge, no large prospective cohort study has previously
ddressed whether increased LVM is an independent risk
actor for a subsequent decrease in LVEF. The Cardiovas-
ular Health Study (CHS), a large multicenter longitudinal
tudy of elderly individuals in which echocardiograms were
erformed at baseline and repeated approximately five years
ater (13,14), afforded the opportunity to address this
mportant question.
ETHODS
tudy population. There were 5,201 participants in the
aseline CHS cohort, a National Heart, Lung, and Blood
nstitute-sponsored prospective cohort study previously de-
cribed in detail (15). Participants were 65 years of age,
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LVH and Subsequent Decrease in LVEF June 16, 2004:2207–15on-institutionalized, and were recruited between 1989 and
990. At baseline, subjects underwent a comprehensive
attery of examinations including laboratory evaluations
btained after a 12-h fast (15,16), electrocardiography, and
chocardiography. Subjects have been followed serially since
he baseline evaluation including a repeat echocardiogram
erformed in 1994 to 1995 (4.9  0.14 years after baseline
tudy), herein termed “follow-up echocardiogram.” The
resent analysis includes those 3,042 participants with a
aseline echocardiographic (n  2,190) or electrocardio-
raphic (n  2,944) assessment of LVM, normal LVEF as
ssessed qualitatively by two-dimensional echocardiography
t baseline, and an assessment of LVEF on the follow-up
chocardiogram (Fig. 1). A second cohort of African-
Abbreviations and Acronyms
BSA  body surface area
CHS  Cardiovascular Health Study
CI  confidence interval
FS  fractional shortening
LV  left ventricular
LVEF  left ventricular ejection fraction
LVM  left ventricular masskFigure 1. Number of participants meeting inclusion criteria.merican subjects was recruited into the CHS between
992 and 1993 and had their baseline echocardiogram in
994 and 1995; given the lack of a follow-up echocardio-
ram, they were not included in the present analysis.
lectrocardiography. Twelve-lead electrocardiograms
ere obtained at baseline and at follow-up and were
nalyzed at a core facility. Left ventricular mass was esti-
ated as previously described (17). Left ventricular hyper-
rophy, Q waves, and atrial fibrillation were defined based
n Minnesota codes (18).
chocardiography. Echocardiographic images were ob-
ained using a standardized protocol and recorded onto
uper VHS tape (13,14). The core reading center for
aseline echocardiograms was located at University of
alifornia-Irvine, and for follow-up echocardiograms at
eorgetown University, Washington, DC. The LVM was
alculated as described by Devereux et al. (19): LVM (g) 
.80  1.04 [(ventricular septal thickness diastole  LV
iastolic dimension  ventricular posterior wall thickness
iastole)3  (LV diastolic dimension)3]  0.6. Expected
VM was calculated for men as 16.6  [weight (kg)]0.51
nd for women as 13.9  [weight (kg)]0.51 as before (1,14).
eft ventricular hypertrophy was defined as an observed/
xpected LVM 1.45 (1,14). Fractional shortening (FS) at
he endocardium and midwall was calculated from M-mode
easurements (20,21). Stress-adjusted FS was calculated,
nd ratios of observed/predicted FS in the lower 5% of a
eference population deemed free of cardiac disease were
onsidered to be depressed (1,21). Left ventricular geometry
as categorized into four mutually exclusive categories
epending upon the presence of LV hypertrophy (observed/
xpected LVM 1.45 as above) and/or increased relative
all thickness (defined as 0.48 [6]). As compared with
ormal geometry, concentric remodeling was defined as
ncreased relative wall thickness but observed/expected
VM 1.45, eccentric hypertrophy as observed/expected
VM 1.45 but no increased relative wall thickness, and
oncentric hypertrophy as increased relative wall thickness
ith observed/expected LVM 1.45.
Qualitative assessment of LVEF was obtained by two-
imensional echocardiography (14). Left ventricular ejec-
ion fraction was classified as normal, borderline, or abnor-
al approximately corresponding to values 55%, 45%
nd 55%, or 45%, respectively (1,10,22). Regional wall
otion was also qualitatively assessed as normal, borderline,
r abnormal (14). To assess agreement for qualitative
ssessment of LVEF between the baseline and follow-up
chocardiography core centers, 238 baseline echocardio-
rams were reinterpreted by the follow-up echocardiogra-
hy core center in a blinded fashion. There was an 87.8%
greement (kappa  0.344) for whether LVEF was normal
r not. This is comparable with assessments of inter-reader
greement of the follow-up echocardiogram (n  250,
greement  86.8%, kappa  0.432) and, as previously
eported, the baseline echocardiogram (agreement  94%,
appa  0.32) (14). Using two sets of baseline echocardio-
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June 16, 2004:2207–15 LVH and Subsequent Decrease in LVEFrams (set one: n 81, set two: n 41), the endocardial FS
as recalculated at follow-up blinded to the original results.
n set one, the original mean FS was 43.2%, and, on blinded
eassessment at follow-up, it was 44.6%. In set two, the
riginal mean FS was 40.7%, and on reassessment it was
5.2%.
efinitions. Hypertension was categorized as present if
eated systolic blood pressure was 140 mm Hg or higher, or
iastolic blood pressure was 90 mm Hg or higher, or the
atient self-reported a history of hypertension in combina-
ion with use of antihypertensive medication. Methods of
scertaining myocardial infarction (23) have been described.
he outcome measure was the development of a depressed
VEF as defined by a borderline or abnormal LVEF on the
ollow-up echocardiogram (see preceding text). These were
rouped together because we have previously shown that
orderline LVEF is an independent risk factor for mortality
22). However, we also performed a sensitivity analysis by
onsidering subjects with follow-up borderline LVEF as
aving not reached the outcome.
tatistical analysis. Continuous variables are expressed as
ean  SD or median (25th, 75th percentile). Differences
n continuous variables were compared with the t test except
or levels of C-reactive protein and serum insulin in which
he Wilcoxon rank-sum test was used due to highly skewed
istributions. The significance of differences in categorical
ariables was assessed by chi-square analysis. Analyses
ncorporating LVM were performed with crude LVM and
VM indexed to body surface area (BSA) or height.
earson correlation coefficients between baseline electrocar-
iographic LVM or baseline echocardiographic parameters
nd follow-up echocardiographic parameters were calcu-
ated. The frequency of the development of depressed
VEF was calculated in the cohort by quartiles of baseline
VM. The Cochran-Armitrage test of trend was used to
etermine the significance of the association of LVM
easures and the development of a depressed ejection
raction. Similar analyses were performed in important
ubgroups.
Logistic regression was used to determine the association
f either baseline LVM or baseline presence of LV hyper-
rophy with incident depressed LVEF. Linear regression
as used to determine the association of LVM with
ollow-up mid-wall FS. Potential confounders including
emographics, baseline height and weight, hypertension
tatus, presence of coronary heart disease, atrial fibrillation,
nd baseline endocardial FS were incorporated as covariates
n multivariable models. We excluded major residual con-
ounding by those variables that were not included in the
nal multivariable models but that differed significantly
etween participants who did or did not reach the outcome
n univariate analysis by adding them back into the final
odel and verifying that the association of the covariate of
nterest and outcome was not changed appreciably. Models
ere also constructed in which LV diastolic dimension wasntered as an independent variable in addition to either LV Leptal wall thickness or posterior wall thickness to determine
hich components of LVM were associated with the
utcome. In a separate set of models, categorical patterns of
V geometry were entered as an independent variable.
nalyses were performed with SPSS software (SPSS Inc.,
hicago, Illinois), and p  0.05 was used as criteria for
tatistical significance.
issing data. A separate analysis was performed to address
he impact of missing data introduced by the requirement to
ave a follow-up CHS echocardiogram. In 131 participants
ho did not have a follow-up CHS echocardiogram but
ere otherwise eligible for inclusion in the present study, we
scertained whether they had developed a depressed LVEF
rom echocardiograms that had been performed as part of
linical care (and had been reassessed by CHS investigators
s previously described [1]). The baseline LVM of those
ho developed a depressed LVEF was compared with the
aseline LVM of the remainder of the subjects without a
ollow-up echocardiogram who did not have a known
istory of heart failure (including heart failure as a cause of
eath).
ESULTS
aseline characteristics, interim clinical events, and follow-
p. The baseline characteristics are shown in Table 1,
tratified by whether baseline LVM was above or below the
edian value (137 g). Subjects with higher LVM were more
ften men with a history of hypertension, diabetes mellitus,
nd prior coronary heart disease. As would be expected, the
omponent measures of LVM (LV diastolic dimension and
osterior wall and septal wall thickness) also differed signif-
cantly between the two groups. When stratifying the cohort
nto quartiles of baseline echocardiographic LVM, the
omponent values of LVM in quartile four were: LV
iastolic dimension 5.4  0.6 cm, septal wall thickness 1.0
0.2 cm, and posterior wall thickness 0.95  0.1 cm. A
orrelation matrix of baseline electrocardiographic LVM
nd echocardiographic parameters with follow-up echocar-
iographic parameters is shown (Table 2) (p  0.001 for all
orrelations). Baseline LV dimensions, echocardiographic
VM, and electrocardiographic LVM were strongly and
irectly related to follow-up LV dimensions and inversely
ith follow-up FS measures. Baseline FS measures were
nversely related to follow-up LV dimensions and directly
elated to follow-up FS measures. During follow-up (Table
), participants who had higher baseline LVM were more
ikely to have a clinical event related to coronary artery
isease (composite measure of myocardial infarction, percu-
aneous coronary angioplasty, or coronary artery bypass
raft). They also were more likely to develop atrial fibrilla-
ion. A number of parameters on the follow-up echocardio-
rams differed between those with a higher or lower baseline
VM.
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LVH and Subsequent Decrease in LVEF June 16, 2004:2207–15ollow-up LV function and its association with baseline
VM. Of the 3,042 participants with baseline assessment
f LVM, 265 (8.7%) developed depressed LVEF during the
5 years of follow-up. Those participants who did reach the
utcome were more likely to have an interval myocardial
nfarction (16%) than those who did not reach the outcome
3%, p  0.001). As would be expected, there were a
umber of significant differences in measurements from the
ollow-up echocardiograms of participants who reached the
able 1. Baseline Clinical Characteristics*
Characteristics
Baseline E
Mass Below t
n  1
ge (yrs) 71.2 
thnicity
Caucasian 1,042 (
African American 45 (
Other 8 (
ale gender 215 (
iabetes mellitus
None 999 (
Fasting blood glucose 125 mg/dl 47 (
History of treated diabetes 40 (
asting glucose (mg/dl) 103 
ypertensive 477 (
moking status
Never 579 (
Former 388 (
Current 127 (
istory of
Coronary heart disease‡ 134 (
Heart failure 14 (
se of medications
ACE-I 42 (
Beta-blockers 115 (
Diuretics 202 (
Calcium channel blockers 89 (
ystolic blood pressure (mm Hg) 131 
eart rate (beats/min) 64 
eight (kg) 65.0 
ody mass index (kg/m2) 25 
erum creatinine (mg/dl) 1.0 
-reactive protein (mg/l) 1.6 (0.8
erum cholesterol (mg/dl) 220 
erum insulin (IU/ml) 11 (9,
lectrocardiographic variables
Atrial fibrillation 16 (
Q waves 26 (
LV hypertrophy 14 (
LV mass (g) 134 
chocardiographic variables
Left atrial dimension (cm) 3.6 
Posterior wall thickness, diastole (cm) 0.77 
Ventricular septal thickness, diastole (cm) 0.79 
LV diastolic dimension (cm) 4.6 
LV systolic dimension (cm) 2.6 
Endocardial FS (%) 43 
Midwall FS (%) 24 
Data are presented as n (%) or means  SD except for C-reactive protein and seru
ass  137 g; ‡coronary heart disease includes myocardial infarction, angina, coron
ACE-I  angiotensin-converting enzyme inhibitors; FS  fractional shortening.utcome as compared with those who did not. These hncluded a larger LV diastolic dimension (5.3  0.8 vs.
.7 0.5), LV systolic dimension (3.6 1.0 vs. 2.7 0.5),
nd left atrial dimension (4.2 0.8 vs. 4.0 0.9), and lower
ndocardial FS (33  11 vs. 43  8), and midwall FS
21  7 vs. 23  4), respectively (p  0.001 for all
omparisons).
The percentage of participants who developed a de-
ressed LVEF, stratified by quartiles of baseline LVM (Fig.
A), LVM indexed to BSA (Fig. 2B), and LVM indexed to
LV
edian†
Baseline Echo LV
Mass Above the Median†
n  1,095 p Value
71.6  4.7 0.038
0.152
1,044 (95.3)
49 (4.5)
2 (0.2)
587 (53.6)  0.001
 0.001
946 (86.6)
82 (7.5)
65 (5.9)
108  28  0.001
638 (58.4)  0.001
 0.001
489 (44.7)
509 (46.6)
95 (8.7)
171 (15.6) 0.026
21 (1.9) 0.307
57 (5.2) 0.150
159 (14.5) 0.005
253 (23.1) 0.008
133 (12.1) 0.002
137  21  0.001
62  10  0.001
75.4  12.7  0.001
27  4  0.001
1.1  0.3  0.001
1.7 (0.9, 3.0) 0.002
207  37  0.001
13 (10, 17)  0.001
30 (2.7) 0.052
43 (4.0) 0.050
44 (4.1)  0.001
161  27  0.001
4.0  0.6  0.001
0.90  0.13  0.001
0.96  0.18  0.001
5.2  0.6  0.001
3.0  0.6  0.001
42  8  0.001
23  4  0.001
lin where median (25th, 75th percentile) is reported; †median left ventricular (LV)
ery bypass grafting, or percutaneous transluminal angioplasty.cho
he M
,095
4.5
95.2)
4.1)
0.7)
19.6)
92.0)
4.3)
3.7)
23
43.8)
52.9)
35.5)
11.6)
12.2)
1.3)
3.8)
10.5)
18.5)
8.1)
20
9
11.1
4
0.2
, 2.7)
38
15)
1.5)
2.5)
1.3)
21
0.6
0.11
0.12
0.4
0.4
7
3
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ary arteight (Fig. 2C), are shown. Irrespective of indexation
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June 16, 2004:2207–15 LVH and Subsequent Decrease in LVEFethod, increasing quartile of LVM was associated with the
evelopment of a depressed ejection fraction. This associa-
ion remained true in a variety of subgroups (Fig. 3).
aseline echocardiographic LVM indexed to BSA was also
ssociated with a decrease in FS from baseline to follow-up
change in FS: 0  9.4 in quartile 1 vs. 1.5  9.9 in
uartile 4 of baseline LVM, p  0.03). In unadjusted
egression models using the entire cohort, baseline electro-
ardiographic and echocardiographic LVM (Table 4) and
V hypertrophy were also each significantly associated with
ncident depressed LVEF and inversely with follow-up
id-wall FS (p  0.005 for all).
ensitivity analysis. A sensitivity analysis was performed
n which subjects with follow-up borderline LVEF were
lassified as having not reached the outcome. A depressed
VEF at follow-up occurred in 2% of participants using this
efinition. Baseline LVM indexed to BSA remained asso-
able 2. Correlation Matrix of Baseline Echocardiographic Param
chocardiographic Parameters*
Follow-Up
Echocardiographic
Parameter
Baseline E
LV Diastolic
Dimension
LV Systolic
Dimension (
V diastolic dimension 0.506 0.470
V systolic dimension 0.397 0.466
S (endocardial) 0.152 0.281
S (midwall) 0.077 0.145
V mass 0.496 0.392
Pearson correlations are shown. Number of observations for correlations ranges from
FS  fractional shortening; LV  left ventricular.
able 3. Interim Clinical Events and Follow-Up Assessment*
Variables
Baselin
Mass Belo
n 
ystolic blood pressure on follow-up (mm Hg) 13
iastolic blood pressure on follow-up (mm Hg) 6
nterim clinical events (%)
Myocardial infarction 3
Heart failure 3
Coronary artery bypass graft 1
Composite CAD event† 4
Angina 8
ollow-up electrocardiogram (%)
Interim Q waves 6
Interim atrial fibrillation 1
ollow-up echocardiogram
Midwall FS (%) 2
Endocardial FS (%) 4
LV hypertrophy† (%) 7
LV mass (g) 12
Left atrial dimension (cm) 3.
LV diastolic dimension (cm) 4.
LV systolic dimension (cm) 2.
LV function
Normal 1,04
Mild decrease 3
Moderate/severe decrease 1
Data are presented as n (%) or mean SD; †interim composite coronary artery diseas
ransluminal angioplasty. Left ventricular (LV) hypertrophy was defined as observedFS  fractional shortening.iated with the outcome (percentage developing a depressed
VEF in quartiles 1 through 4 of baseline echocardio-
raphic LVM indexed to BSA was: 1.1%, 0.5%, 1.1%, and
.6%, respectively; p  0.001). Using quartiles of baseline
lectrocardiographic LVM index, the percentage of partic-
pants developing a depressed LVEF was 0.3%, 1.4%, 2.7%,
nd 3.4%, respectively (p  0.001). The risk ratio for the
evelopment of a depressed LVEF associated with quartile
of baseline echocardiographic LVM index as compared
ith quartile 1 was 4.3 (95% confidence interval (CI) 1.8 to
0.6; p  0.001).
ultivariable analysis. In multivariable models that ad-
usted for potential confounders, baseline electrocardio-
raphic and echocardiographic LVM were each indepen-
ently associated with the development of depressed LVEF
nd inversely with follow-up midwall FS (Table 4). The
esults were nearly identical when baseline midwall FS was
s or Electrocardiographic LV Mass With Follow-Up
ardiogram
Baseline
Electrocardiographic
LV Mass
S
cardial)
FS
(Midwall) LV Mass
.228 0.093 0.472 0.434
.319 0.184 0.363 0.346
.276 0.188 0.125 0.142
.144 0.151 0.144 0.133
.123 0.084 0.603 0.534
6 to 2,126. p  0.001 for all correlations.
o LV
Median
5
Baseline Echo LV
Mass Above the Median
n  1,095 p Value
0 135  21 0.003
1 69  11 0.345
) 53 (5.1) 0.108
) 75 (6.9)  0.001
) 47 (4.4)  0.001
) 88 (8.6)  0.001
) 153 (15.4)  0.001
) 100 (9.6) 0.001
) 41 (3.8) 0.001
23  4  0.001
42  9  0.001
) 176 (21.9)  0.001
2 170  47  0.001
.6 4.2  1.2  0.001
.5 5.0  0.6  0.001
.5 3.0  0.7  0.001
 0.001
.7) 973 (88.9)
) 92 (8.4)
) 30 (2.7)
D) event included myocardial infarction, coronary artery bypass graft, or percutaneous
ted LV mass ratio 1.45 as before (1,14).eter
choc
F
Endo
0
0
0
0
0
1,65e Ech
w the
1,09
2  2
9  1
8 (3.6
0 (2.8
4 (1.3
8 (4.6
9 (8.8
0 (5.6
7 (1.6
3  4
3  8
4 (8.3
7  3
8  0
5  0
6  0
8 (95
7 (3.4
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LVH and Subsequent Decrease in LVEF June 16, 2004:2207–15ncorporated as a covariate instead of baseline endocardial
S. Similarly, when LVM indexed to BSA was entered as a
ovariate instead of crude LVM (height and weight re-
oved from models) or when baseline blood glucose or
lood pressure were entered into the models as covariates
nstead of diabetes or hypertension status, the results were
ssentially identical to those shown in Table 4. The risk
atio associated with baseline echocardiographic LV hyper-
rophy for incident depressed LVEF in multivariable anal-
sis using the same confounders as in Table 4 was 2.2 (95%
I 1.3 to 3.4; p 0.001). In multivariable analyses stratified
y gender using the same covariates as in Table 4, the
ssociation between LVM (per 50.9 g) and development of
depressed LVEF persisted in women (risk ratio 1.6 [95%
I 1.1 to 2.4; p  0.02]) and in men (risk ratio, 1.5 [95%
I 1.1 to 2.1; p  0.02]).
entricular diastolic dimension, wall thickness, and their
ssociation with depressed ejection fraction. Because
chocardiographic LVM is a calculation derived from LV
iastolic dimension and wall thickness (ventricular septum
nd LV posterior wall), we assessed which of these subcom-
onents of calculated LVM was associated with the out-
ome. A series of models was constructed in which LV
iastolic dimension was entered with either ventricular
eptal or posterior wall thickness as independent variables
Table 4). In the analyses that included diastolic dimension
nd septal wall thickness, both remained associated with the
igure 3. Subgroup analysis: percentage of participants developing a
epressed left ventricular ejection fraction by baseline quartile of echocar-
iographic left ventricular mass (LVM) indexed to body surface area
BSA). “No coronary artery disease” subgroup consisted of participants
ithout prevalent or interval myocardial infarction, coronary artery bypass
rafting, or percutaneous transluminal angioplasty. “No diabetes” and “no
eart failure” excluded participants with these conditions present at
aseline, and “no atrial fibrillation” excluded those with atrial fibrillation at
aseline or during follow-up. P  0.001 for the association of LVM/BSA
nd incident depressed ejection fraction for all groups shown. White bars
quartile 1; bars with horizontal lines  quartile 2; bars with diagonal
ines  quartile 3; black bars  quartile 4. Quartile values of echocardio-
raphic LVM/BSA are as reported in Figure 2.igure 2. Percentage of participants developing a depressed left ventricular
jection fraction by baseline quartile of left ventricular mass (LVM) (A)
nd LVM indexed to body surface area (BSA) (B) or height (C). Baseline
VM was assessed by echocardiography or electrocardiography (ECG). P
0.001 for the association of LVM irrespective of indexation method with
ncident depressed ejection fraction in all cases. White bars  quartile 1;
ars with horizontal lines  quartile 2; bars with diagonal lines 
uartile 3; black bars  quartile 4. Quartiles of echocardiographic LVM
g): 114.7, 114.8 to 137.2, 137.4 to 165.7, 165.7, respectively.
uartiles of electrocardiographic LVM (g): 128.1, 128.1 to 145.4,
45.43 to 167.2, and 167.2, respectively. Quartiles of echocardiographic
VM/BSA (g/m2): 67.7, 67.8 to 79.2, 79.3 to 93.5, and 93.5,
espectively. Quartiles of electrocardiographic LVM/BSA (g/m2): 76.9,
6.9 to 83, 83.1 to 90.3, and 90.3, respectively. Quartiles of echocardio-
raphic LVM/height (g/m): 70.40, 70.42 to 84.13, 84.14 to 99.97, and
99.97, respectively. Quartiles of electrocardiographic LVM/height (g/m):
79.48, 79.49 to 88.51, 88.52 to 99.49, and 99.49, respectively. evelopment of a depressed LVEF and lower follow-up
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June 16, 2004:2207–15 LVH and Subsequent Decrease in LVEFidwall FS. However, in the adjusted models in which both
V diastolic dimension and posterior wall thickness were
ncluded as independent variables, there was no significant
ssociation of posterior wall thickness with incident de-
ressed LVEF.
The baseline geometry of the LV was classified as being
ormal (n  1,856) or as having concentric remodeling (n 
4), eccentric hypertrophy (n  218), or concentric hypertro-
hy (n 26). The percentage of participants who developed a
epressed LVEF at follow-up among these four groups was
.7%, 8.3%, 16.5%, and 3.8%, respectively (p  0.001). In
djusted multivariable models using the same covariates as in
able 4, eccentric hypertrophy remained associated with the
evelopment of a depressed LVEF (relative risk 2.3; 95% CI
.4 to 3.6) but concentric remodeling (relative risk 1.2; 95% CI
.4 to 3.5) and concentric hypertrophy (relative risk 0.8; 95%
I 0.1 to 6.3) did not.
articipants excluded due to a missing follow-up echo-
ardiogram. Of 5,201 participants in CHS, 1,581 were
xcluded from analysis in this study due to the lack of a
able 4. Unadjusted and Adjusted Regression Analysis
Outcome: Depresse
Independent Variables†
Unadjuste
Risk Rati
chocardiographic LV mass
(per 50.9 g)
1.8
lectrocardiographic LV mass
(per 39.2 g)
2.0
V diastolic dimension and
septal wall thickness§
Diastolic dimension
(per 0.8 cm)
2.0
Septal thickness
(per 0.2 cm)
1.3
V diastolic dimension and
posterior wall thickness§
Diastolic dimension
(per 0.8 cm)
2.0
Posterior wall thickness
(per 0.2 cm)
1.3
Outcome: Follow-Up Midwa
Independent Variables†
Unadjuste
-Coefficie
chocardiographic LV mass
(per 50.9 g)
0.6
lectrocardiographic LV mass
(per 39.2 g)
0.6
V diastolic dimension and
septal wall thickness§
Diastolic dimension
(per 0.8 cm)
0.5
Septal thickness
(per 0.2 cm)
0.7
V diastolic dimension and
posterior wall thickness§
Diastolic dimension
(per 0.8 cm)
0.5
Posterior wall thickness
(per 0.2 cm)
0.4
Logistic regression was used for the outcome of depressed ejection fraction and line
f change for all independent variables; ‡Adjusted for age, gender, white race, height
tatus (including myocardial infarction, percutaneous angioplasty, or coronary artery
aseline or during follow-up). Models incorporating echocardiographic and electrocar
hortening; §Both LV diastolic dimension and wall thickness (either septal or posteollow-up echocardiogram with an assessment of LVEF as dresult of death (n  533), loss of contact (n  229), a
ollow-up echocardiogram without assessment of LVEF (n
179), and a follow-up visit with no echocardiogram
btained (e.g., home visit, nursing home visit, or phone
nformation only; n  640). In comparing participants who
id not have a follow-up echocardiogram with an LVEF
ssessment to those who did, the former were older (74 
years vs. 72  5 years, respectively), had a higher
roportion of men (44% vs. 39%), diabetes (10.2% vs.
.3%), hypertension (62% vs. 53%), atrial fibrillation (3.7%
s. 1.8%), larger echocardiographic baseline LVM (154 
4 g vs. 145  44 g), and lower baseline mid-wall FS (23
% vs. 24  4%); p  0.005 for all comparisons.
Of 1,581 subjects without a CHS follow-up echocar-
iogram, 131 had an echocardiogram performed for
linical care that subsequently had been reviewed by CHS
nvestigators (1). Of these, 69 subjects had a depressed
VEF. The baseline echocardiographic LVM indexed to
SA was higher in those subjects who developed a
epressed LVEF (n  42) as compared with the remain-
Ejection Fraction*
95%
Confidence
Intervals p Value
Adjusted‡
Risk Ratio
95%
Confidence
Intervals p Value
1.5, 2.0  0.001 1.5 1.2, 1.8  0.001
1.7, 2.3  0.001 1.5 1.2, 1.8  0.001
1.7, 2.4  0.001 1.8 1.4, 2.2  0.001
1.1, 1.6 0.001 1.2 1.0, 1.5  0.05
1.6, 2.4  0.001 1.7 1.4, 2.1  0.001
1.1, 1.6 0.005 1.1 0.9, 1.4 0.27
ctional Shortening Percent*
95%
Confidence
Intervals p Value
Adjusted‡
-Coefficient
95%
Confidence
Intervals p Value
0.86, 0.4  0.001 0.5 0.7, 0.1 0.001
0.9, 0.4  0.001 0.1 0.4, 0.02 0.4
0.8, 0.2  0.001 0.4 0.7, 0.1 0.01
0.9, 0.4  0.001 0.5 0.8, 0.3  0.001
0.7, 0.2 0.001 0.3 0.6, 0.05 0.02
0.7, 0.2  0.001 0.3 0.5, 0.01 0.06
ession for midwall fractional shortening; †Interquartile ranges were used as the unit
ne weight, diabetes or hypertension at baseline, baseline and interval coronary artery
graft), and presence of Q waves or atrial fibrillation on electrocardiogram (either at
phic left ventricular (LV) mass were also adjusted for baseline endocardial fractional
ll) were entered as covariates in the same model.d LV
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SA 98  29 g/m2 vs. 86  26 g/m2, respectively; p 
.002). A similar relationship was seen with baseline
lectrocardiographic LVM indexed to BSA in comparing
hese two groups (92  15 [n  67] g/m2 vs. 85  12 [n
1,225] g/m2, respectively; p  0.001).
ISCUSSION
eft ventricular hypertrophy is associated with a number of
dverse clinical outcomes including the development of
eart failure (1–7). However, because LV hypertrophy is
lso associated with diastolic dysfunction, which may also
ause heart failure (11,12), it has been unclear whether
ncreased LVM and LV hypertrophy predispose to a de-
ressed LVEF in humans. Echocardiographic studies that
ave associated increased LVM with subtle abnormalities in
ystolic function, such as midwall FS (20,21,24), and earlier,
mall case series of patients with various stages of hyperten-
ive heart disease (25,26) have been cross-sectional in
ature. As such, they did not clarify whether ventricular
ypertrophy led to the ventricular systolic dysfunction, or
hether the hypertrophy resulted from changes in systolic
unction and ventricular dilation (27). Recent data have
hown that changes in LVM while on antihypertensive
herapy are inversely related to changes in systolic function
28,29).
The CHS database has detailed measurements of cardiac
imensions including LVM, and, by restricting our analysis
o those subjects with a normal LVEF at baseline, we found
n association between baseline LVM and LV hypertrophy
ith incident depressed LVEF at a follow-up of 5 years.
he LVM remained associated with incident depressed
VEF in important subgroups including women; those
ith no evident baseline abnormalities of systolic function
s measured by stress-adjusted FS and regional wall motion
core; those free of coronary heart disease at baseline and at
ollow-up; those without diabetes, prevalent heart failure, or
trial fibrillation. In addition to its association with the
evelopment of a depressed LVEF, baseline LVM was also
ssociated with lower midwall FS at follow-up. The asso-
iation of LVM and LV hypertrophy with incident de-
ressed LVEF was independent of potential confounders in
ultivariable analysis. In total, these data show that LVM
nd LV hypertrophy are risk factors for the development of
depressed LVEF within five years in older adults.
actors contributing to fall in LVEF. The mechanisms
y which increased LVM leads to a depressed LVEF remain
ll-defined. Myocardial infarction is traditionally viewed as
n obligatory event in the transition to depressed systolic
unction (30), and is an important risk factor, occurring in
6% of those who did develop a depressed LVEF as
ompared with 3% of those who did not. However, the
resent study also demonstrates that there must be other
echanisms operative, because increased LVM remainedssociated with the development of depressed LVEF in tarticipants free of clinically manifest coronary heart disease
ncluding myocardial infarction (Fig. 3). Potential mecha-
isms that have previously been shown to be associated with
ncreased LVM are neurohormonal activation (31) and
bnormalities in myocyte perfusion even in the absence of
picardial coronary artery stenoses (32).
entricular wall thickness and chamber dimension. An
ncrease in LVM may occur either through an increase in
V chamber dimensions or wall thickness. Previous data
howing increased echocardiographic LVM to be associated
ith adverse clinical outcomes have not assessed whether
hese relationships were true for both chamber dilation and
ncreased wall thickness (3–5). The Framingham Heart
tudy investigators have shown that increased LV cavity size
s associated with a number of adverse outcomes including
eart failure (33,34). Our study is the first to our knowledge
o show that LV diastolic dimension and ventricular septal
all thickness are associated, independently of each other,
ith the development of a depressed LVEF and a decrease
n mid-wall FS. The importance of LV dilation as a risk
actor for the subsequent fall in LVEF is reinforced by the
ssociation of eccentric hypertrophy (increased LVM due to
ncreased LV volume with normal relative wall thickness)
ut not concentric hypertrophy with the development of a
epressed LVEF in multivariable models.
tudy limitations. There are important limitations in this
nalysis. The development of a depressed LVEF may be
econdary to a difference in echocardiographic interpreta-
ion that occurred over the five years of follow-up. However,
ther echocardiographic parameters were consistent with a
rue difference between the two groups, and blinded rein-
erpretation at follow-up of baseline studies had estimates of
S that were higher rather than lower than the original
alues. The true incidence of depressed LVEF cannot be
alculated due to the lack of a follow-up echocardiogram in
sizable fraction of the participants. Given that the partic-
pants who did not have follow-up echocardiograms had
ower midwall FS at baseline than the participants who did
ave follow-up echocardiograms, the true percentage of
articipants who progressed to a depressed LVEF is likely
igher than we found. Although a considerable number of
ubjects had missing follow-up CHS echocardiograms and
ere excluded from the primary analysis, the association of
VM and depressed LVEF appeared robust in those
articipants as ascertained by an analysis of echocardiograms
btained for clinical care. The LVEF is afterload-dependent
nd likely underestimated the baseline presence of LV
ystolic dysfunction (21). However, the LVEF is the most
ommon measure of systolic function, and a reduced LVEF
as immediate clinical applicability.
onclusions. We have shown that increased LVM,
hether measured by the electrocardiogram or echocardio-
ram, is an independent risk factor for the subsequent
evelopment of a depressed LVEF in older adults at 5
ears of follow-up. An eccentric pattern of cardiac hyper-
rophy as occurs with LV chamber dilation is a particularly
s
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June 16, 2004:2207–15 LVH and Subsequent Decrease in LVEFtrong risk factor for this outcome. The association between
ncreased LVM and development of depressed LVEF per-
ists even among subjects without myocardial infarction,
uggesting that there are additional pathophysiologic mech-
nisms through which increased LVM is associated with a
ubsequent fall in the LVEF.
eprint requests and correspondence: Dr. Mark H. Drazner,
323 Harry Hines Boulevard, Dallas, Texas 75390-9047. E-mail:
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